Cargando…
Glibenclamide for the Treatment of Acute CNS Injury
First introduced into clinical practice in 1969, glibenclamide (US adopted name, glyburide) is known best for its use in the treatment of diabetes mellitus type 2, where it is used to promote the release of insulin by blocking pancreatic K(ATP) [sulfonylurea receptor 1 (Sur1)-Kir6.2] channels. Durin...
Autores principales: | Kurland, David B., Tosun, Cigdem, Pampori, Adam, Karimy, Jason K., Caffes, Nicholas M., Gerzanich, Volodymyr, Simard, J. Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817601/ https://www.ncbi.nlm.nih.gov/pubmed/24275850 http://dx.doi.org/10.3390/ph6101287 |
Ejemplares similares
-
Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke
por: Caffes, Nicholas, et al.
Publicado: (2015) -
The Protective Effect of Glibenclamide in a Model of Hemorrhagic Encephalopathy of Prematurity
por: Tosun, Cigdem, et al.
Publicado: (2013) -
Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of Stroke
por: Simard, J. Marc, et al.
Publicado: (2012) -
Changes in Diffusion Kurtosis Imaging and Magnetic Resonance Spectroscopy in a Direct Cranial Blast Traumatic Brain Injury (dc-bTBI) Model
por: Zhuo, Jiachen, et al.
Publicado: (2015) -
MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury
por: Simard, JM, et al.
Publicado: (2013)